Skip to content

Physical Activity and Obesity

Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02060240
Enrollment
30
Registered
2014-02-12
Start date
2014-02-28
Completion date
2017-04-30
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Prediabetic State, Sedentary Lifestyle

Keywords

Obesity, Prediabetic State, Sedentary Lifestyle, Insulin Resistance, Endothelium, Eicosanoids, Nitric Oxide, Regional Blood Flow

Brief summary

The purpose of the study is to see if a twelve-week exercise intervention in overweight or obese subjects with pre-diabetes or early disease course type 2 diabetes can lead to improved skeletal muscle capillary blood flow by improving substances that dilate blood vessels and result in improved insulin sensitivity.

Interventions

BEHAVIORALHigh Activity

The high activity group will undergo a 12 week ramped exercise protocol.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Males and females ages 30-60 years of age 2. Overweight and Obese (28\< BMI \<45) 3. Confirmed pre-diabetic (5.7≤ HbA1c \< 6.5) 4. Type 2 DM, Diagnosis 2 years or less, on no medications or metformin only, HbA1c ≤ 6.7

Exclusion criteria

1. Stage 3 chronic kidney disease (glomerular filtration rate \[GFR\] \< 60) 2. Obstructive Coronary artery disease 3. Congestive heart failure (ejection fraction \< 55%) 4. Peripheral vascular disease, 5. Degenerative joint disease, musculoskeletal disease, or peripheral vascular disease that limits ability to exercise 6. Know hypersensitivity to Definity® ultrasound contrast agent 7. Intra-cardiac or pulmonary shunt 8. The use of antithrombotic agents or a severe bleeding diathesis due to risk of bleeding with intravenous and arterial line placement 9. Physical activity greater than three hours per week 10. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Insulin mediated skeletal muslce blood flow and capillary recruitment3 monthsContrast enhanced ultrasound skeltal muscle perfusion imaging will be performed at rest and during glucose steady state infusion during an insulin clamp. The change in blood flow will be determined between the resting state and at peak steady state to determine the absolute increase in skeletal muslce blood flow (ml/min/g) as well as the absolute increase in capillary blood volume (ml/g) of tissue

Secondary

MeasureTime frameDescription
Quantification of endothelial derived Vasodilators3 monthsTo quantify the changes in endothelial derived vasodilators. For this aim nitric oxide bioavailability as tested by flow mediated vasodilation will be performed and reported as absolute change (cm) and percent change (%) in brachial artery diameter from baseline to post ischemic occlusion of the forearm. Plasma samples for eicosanoids will be collected and assessed by liquid chormatography/mass spectroscopy to to assess changes in endothelial derived vasodilators.

Other

MeasureTime frameDescription
Correalte changes in fitness to vasodilators, blood flow, and insulin sensitivity3 monthsAim 3. To correlate changes in fitness as measured by peak VO2 and anaerobic threshold during cardiopulmonary exercise testing with changes in endothelial derived vasodilators, skeletal muscle blood flow, and insulin sensitivity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026